🧪
Healthcare & Biotech Regulatory Redlines & Legal Risk 2013 - 2015

研究者主导试验的数据争议 (Novartis Japan):公司没有直接做这项研究,为什么还是被处分了?

「不是我们做的研究」不能成为免责理由,参与就是责任

研究者主导试验的数据争议 (Novartis Japan):巅峰期跨国药企在日本的重要业务实体,其高血压治疗药物在日本市场被广泛使用,公司通过学术推广与研究合作维持产品在临床中的地位;终局是员工参与的研究者主导试验被查出数据问题,公司未充分披露参与情况,监管机构作出行政处分,产品推广受限,公司声誉与内部合规流程受到系统性审查。

Official site
See the patterns

About this link:原地址会跳转到站内其他页面。

公开报道整理 待核查 Figures as of 2015 2 sources(1 primary) What do these mean?

How to read this bar

This bar states plainly what we know and what we have checked, so you can judge it yourself.

· Review status: “pending” means no editor has checked it against the sources yet; “checked” means key facts match the sources.

· Figures as of: the year the numbers are current to; later changes are out of scope.

· Sources: listed one by one at the bottom of the page. “Primary” means official filings, annual reports or regulator documents.

· Corrections: every change and its basis is published — nothing is edited silently.

Editorial policy → Editorial policy: the full inclusion rules, verification process, AI disclosure and correction promise.

No English translation for this case yet — showing the stored original.
Peak valuation

跨国药企在日本的重要业务实体,其高血压治疗药物在日本市场被广泛使用,公司通过学术推广与研究合作维持产品在临床中的地位

Final cost

员工参与的研究者主导试验被查出数据问题,公司未充分披露参与情况,监管机构作出行政处分,产品推广受限,公司声誉与内部合规流程受到系统性审查

Attribution votes

5,104 votes cast

Community output

1 plans · 1 insights

Sponsored
把你亲历的失败写进来

投稿会先进入待审,通过后才进入公开目录和站点地图。

Root Causes Consensus Poll

Vote for the primary fatal error that caused this enterprise to collapse.

外部合规

员工参与研究但披露不充分

参与设计与统计支持未被如实说明,影响研究独立性认定

1,679 votes (33%)
产品技术

研究数据管理存在缺陷

数据处理与审核流程不严,结果可信性受到质疑

1,410 votes (28%)
组织管理

推广与研究之间的界限模糊

研究结果被用于推广,使学术活动与商业目的混同

1,142 votes (22%)
资本财务

处分与推广受限带来损失

行政处分影响产品推广与销售,长期合规成本上升

873 votes (17%)

Sources

2 sources · 1 primary

These are the references used to compile this case; the numbers match the [1][2] marks in the timeline. Primary sources come first, and archive links are kept where possible.

1 of these are overseas sites (Wikipedia, the Internet Archive, etc.) that may be unreachable from mainland China, so domestic sources (Baidu Baike, mainstream financial media, exchange filings) have been added wherever possible.

  1. [1]
    官方网站(Wikidata 登记) Primary 官方资料
    novartis.com Accessed 2026-10-04
  2. [2]
    维基百科:Novartis 其他 Overseas site
    Wikipedia Accessed 2026-10-04